Your browser doesn't support javascript.
loading
Molecular and cellular effects of a novel hydroxamate-based HDAC inhibitor - belinostat - in glioblastoma cell lines: a preliminary report.
Kusaczuk, Magdalena; Kretowski, Rafal; Stypulkowska, Anna; Cechowska-Pasko, Marzanna.
Afiliação
  • Kusaczuk M; Department of Pharmaceutical Biochemistry, Medical University of Bialystok, Mickiewicza 2A, 15-222, Bialystok, Poland. mkusaczuk@wp.pl.
  • Kretowski R; Department of Pharmaceutical Biochemistry, Medical University of Bialystok, Mickiewicza 2A, 15-222, Bialystok, Poland.
  • Stypulkowska A; Department of Pharmaceutical Biochemistry, Medical University of Bialystok, Mickiewicza 2A, 15-222, Bialystok, Poland.
  • Cechowska-Pasko M; Department of Pharmaceutical Biochemistry, Medical University of Bialystok, Mickiewicza 2A, 15-222, Bialystok, Poland.
Invest New Drugs ; 34(5): 552-64, 2016 10.
Article em En | MEDLINE | ID: mdl-27468826
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sulfonamidas / Glioblastoma / Inibidores de Histona Desacetilases / Ácidos Hidroxâmicos / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sulfonamidas / Glioblastoma / Inibidores de Histona Desacetilases / Ácidos Hidroxâmicos / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article